Company Is Honored for Its Commitment

Published Online: Thursday, July 1, 2004

On May 8, 2004, Novo Nordisk received the Angel Award for its dedication to improving the lives of individuals with diabetes and its unwavering focus on treating and preventing diabetes worldwide. The award was presented at the Los Angeles Chapter of the Juvenile Diabetes Research Foundation's (JDRF) annual gala benefiting the Stem Cell Research Fund.

Along with its work with the JDRF, Novo Nordisk is active in a number of initiatives as part of the company's dedication to social responsibility. The company recently launched the Diabetes Aware campaign with the Entertainment Industry Foundation to educate Americans about the importance of detection, monitoring, and proper management of this chronic, progressive disease.

Latest Articles
Having trouble getting your hands on FluMist?
Novartis is paying $390 million to settle charges that it paid kickbacks to pharmacies to encourage drug sales.
Anxiety sensitivity has been linked to more debilitating asthma symptoms and greater functional limitations.
Nasal corticosteroid sprays do not seem to be viable treatments for the common cold.
Latest Issues